Remove Quality of Life Remove Reimbursement Remove Research
article thumbnail

The potential of artificial intelligence to revolutionize health care delivery, research, and education in cardiac electrophysiology

HeartRhythm

The field of electrophysiology (EP) has benefited from numerous seminal innovations and discoveries that have enabled clinicians to deliver therapies and interventions that save lives and promote quality of life.

article thumbnail

Cardiac Dimensions Appoints Satya Shreenivas, MD, as Chief Medical Officer

DAIC

His industry roles have included serving as Chief Medical Officer for HLT Medical, a transcatheter heart valve company, as Chief of Cardiology with Optum/United Health subsidiary SCA Health, and as Medical Director for clinical research organization Medpace.

article thumbnail

Revolutionizing Hypertension Treatment: The Promise of Renal Denervation

Wellnest

Hence, to reduce the risk of CVDs, regular diagnosis using advanced tools like the , Wellnest 12L ECG Machine and modern therapies such as Renal Denervation for treatment is needed to improve the health and quality of life of individuals with resistant blood pressure.

article thumbnail

Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure

DAIC

BioCardia previously confirmed alignment with the United States Food and Drug Administration (FDA) on the design of the 250-patient randomized, controlled trial and the minimum of 12-month primary composite endpoint of all cause death, reduction in major adverse cardiovascular events, and improvement in quality of life.

article thumbnail

BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study

DAIC

CMS previously published a New Technology APC (Ambulatory Payment Classifications) code that covers the CardiAMP Cell Therapy investigational study procedure, including the BioCardia investigational products utilized to perform the study procedure, allowing the study centers to be reimbursed for the study procedure and products.

CMS 111